Glioblastoma (GB) is a devastating disease for which new treatment modalities are needed. Efficacious therapy requires the removal of stem-cell like cells, these cells drive tumor progression because of their ability to self-renew and differentiate. In glioblastoma, the GB stem-like cells (GSC) form a small population of tumor cells and possess high resistance to chemo and radiation therapies. To assess the sensitivity of GSC to reovirus-mediated cytolysis, a panel of GSC cultures was exposed to wild-type reovirus Type 3 Dearing (T3D) and its junction adhesion molecule-A (JAM-A)-independent mutant, jin-1. Several parameters were evaluated, including the fraction of cells expressing the JAM-A reovirus receptor, the fraction of cells synthesizing reovirus proteins, the number of infectious reovirus particles required to reduce cell viability, the amount of infectious progeny reovirus produced and the capacity of the reoviruses to infect the GSC in 3-dimensional (3D) tumor cell spheroids. Our data demonstrate a marked heterogeneity in the susceptibility of the cultures to reovirus-induced cytolysis. While in monolayer cultures the jin-1 reovirus was generally more cytolytic than the wild-type reovirus T3D, in the 3D GSC spheroids, these viruses were equally effective. Despite the variation in reovirus sensitivity between the different GSC cultures, our data support the use of reovirus as an oncolytic agent. It remains to be established whether the variation in the reovirus sensitivity correlates with a patient's response to reovirus therapy. Moreover, our data show that the expression of the JAM-A receptor is not a major determinant of reovirus sensitivity in 3D GSC cultures.
INTRODUCTION
Treatment of glioblastoma (GB) remains a significant clinical challenge. Despite intensive treatment, which includes surgical resection, followed by chemo-irradiation therapy, the prognosis remains infaust. This is largely due to the high tumor recurrence rate caused by the highly infiltrative and aggressive nature of these tumors. Despite the extensive research in the past decades, the patient survival rates have only incrementally improved. 1 An important role in the recurrence of GBs has been assigned to a small population of cells, the GB stem-like cells (GSC). [1] [2] [3] These cells possess high resistance to radio-and chemotherapy [4] [5] [6] and can self-renew and differentiate into the heterogeneous cell types that drive tumorigenesis. 2, 7, 8 Additionally, genotypic and phenotypic analyses of cultured GSC revealed that they retain the molecular characteristics of the parental tumors better than cells cultured in conventional serum-containing media. 7, 8 The notion that GSCs are relatively resistant to the conventional radiation and chemotherapies stresses the importance of exploring other means of eliminating these cells. An approach that has gained much interest for cancer treatment over the past decades is virotherapy. So far, at least fifteen different viruses have been evaluated in preclinical studies. Of these, at least four, that is, herpes simplex virus, human adenovirus, Newcastle disease virus and mammalian reovirus, have been evaluated in clinical studies for the treatment of GB. The results demonstrated that the approach is safe and well tolerated, and provided anecdotal evidence of anti-tumor efficacy (as reviewed in Wollman et al. 9 and Zemp et al. 10 ) Nevertheless, these studies revealed that the therapeutic efficacy needs further improvement. One way to accomplish this is to focus the treatment modalities by identifying those tumors and patients who are more likely than others to respond to a specific therapy.
Here we evaluated the susceptibility of a panel of cultured GSCs, isolated from tumor resections of GB patients, to mammalian reovirus Type 3. Reovirus Type 3 Dearing (T3D) has been evaluated extensively as oncolytic agent. It has a segmented double-stranded RNA genome. Reovirus attachment and entry are mediated by the junction adhesion molecule-A (JAM-A), which is an integral tight junction protein. 11, 12 Research indicates that the absence or incorrect expression of JAM-A on colorectal tumor cells inhibits reovirus infection. 13 In addition, upon infection, reoviruses preferentially lyse cells with an activated RAS/RalGEF/p38 pathway. [14] [15] [16] This tumor cell preference leads to the initiation of at least 30 clinical studies involving the use of wild-type (wt) T3D as oncolytic agent. 17 So far, one phase-I clinical trial involving intratumoral administration of reovirus to patients with recurrent malignant glioma was completed. This study showed that this approach is safe and well tolerated, but anti-tumor efficacy has been limited. 18 To evaluate the capacity of reovirus to establish a lytic infection in brain tumor stem cells, we assessed the cytolytic capacity of reoviruses in GSC cultures. First, the expression of the canonical mammalian reovirus receptor, JAM-A, 11 was analyzed by flow cytometry. A wide heterogeneity in JAM-A expression between the GSC cultures was observed. Therefore, the susceptibility to wt T3D was compared with the susceptibility to the T3D mutant jin-1. This mutant, in contrast to wt T3D, can infect cells independent of JAM-A expression. 19 To evaluate the susceptibility of the GSCs, early viral protein synthesis, the virus-induced cytopathic effect and progeny virus yields were determined. Progeny virus yields are relevant, as virus spread and amplification are dependent on progeny production. Moreover, virus penetration and spread in 3-dimensional (3D) GSC spheroid cultures were determined. The 3D cultures serve as an intermediate between monolayer cultures and animal model systems, and these 3D cultures may mimic the intratumor environment more than monolayer cultures. 20, 21 Moreover, distribution, spread and oncolysis can be studied in 3D spheroid models. 22 Our data reveal a wide heterogeneity in reovirus susceptibility among the different GSC cultures and that the reovirus replication can be hampered at various stages of infection. In addition, we demonstrate that the jin-1 mutant infects cells more efficient in GSCs in monolayer cultures, is more cytolytic and produces more progeny virus upon GSC infection. However, in 3D GSC spheroid cultures, the pattern of viral spread and infection of jin-1 was similar to wt T3D.
MATERIALS AND METHODS

Cell lines
The established cell lines 911 and U118MG were cultured in high glucose Dulbecco's modified Eagle medium (DMEM) (Invitrogen, Breda, The Netherlands), supplemented with penicillin, streptomycin (pen-strep) and 8% fetal bovine serum (Invitrogen, Bleiswijk, The Netherlands). A detailed protocol for establishment of GSC cultures from glioma resection specimens is described elsewhere. 23 In brief, GSCs were grown on growth factor-reduced extracellular matrix-(Cultrex BME Reduced Growth Factor, R&D systems, Abingdon, UK) coated dishes and cultured in DMEM-F12 supplemented with 1% pen-strep, B27 (Invitrogen), human EGF (5 mg ml À 1 ), human basic FGF (5 mg ml À 1 ) (both Tebu-Bio, Heerhugowaard, The Netherlands) and heparin (5 mg ml 
Reovirus
The wt mammalian reovirus Type 3 Dearing strain R124 (referred in the text as wt T3D), and the jin-1 mutant were propagated as described before. 19 Cultures of 911 cells were exposed to wt T3D in DMEM 2% fetal bovine serum. At 4 h post infection, the medium was replaced with DMEM 8% fetal bovine serum. The wt T3D virus was harvested 48 h after infection by collecting the cells in 2% fetal bovine serum/phosphate-buffered saline and the virus was released by three cycles of freeze-thawing. The jin-1 virus was propagated on the JAM-A-deficient cell line, U118MG, and was harvested at 72 h post infection. Infectious titers of both viruses were determined by plaque assay on 911 cell cultures.
Cell viability assay
Cells were infected in suspension with wt T3D or jin-1 at a multiplicity of infection (MOI) range 0-100 pfu 911 per cell. Subsequently cells were transferred to an EMC growth factor-reduced pre-coated 96-well plate in which 10 000 cells per well were seeded. The viability of the cultures was measured 72 h post infection by CellTiter-Glo Luminescent Cell Viability assay, according to manufacturer's instructions (Promega, Leiden, The Netherlands). Briefly, the reagent was added to the cell cultures and incubated at room temperature in the dark for 10 min. Next, samples were transferred to black 96-well plates and luminescence was measured by a plate reader (Tecan Infinite M200, Tecan Group Ltd, Männedorf, Switzerland). Luminescence count data of the plate reader were transferred to Microsoft office Excel and half maximal effective concentration (EC 50 ) values were calculated from the mean residual luminescence from three independent samples. 
Flow cytometry analysis
Viral progeny
Cells were exposed in suspension at 37 1C for 1 h with wt T3D or jin-1, MOI ¼ 3 pfu 911 per cell. Next, unbound virus was removed by centrifugation, removal of the medium and plating the cells in fresh medium in 24-well plates. After 72 h, cells and media were collected and freeze-thawed three times to release virus from the cells. Viral titers were determined by plaque assays on 911 cells as described. 24 The plaque titration conditions used have an inter-experimental variation of o15%. The virus production by the cell cultures was expressed as the fold-increase and calculated by dividing the total yield by the amount of virus used to infect the culture.
Spheroid 3D cultures
Multicellular spheroids were generated by seeding 10 000 cells per well in a non-adherent 96-well round-bottom plate in culture media supplemented with 2.4% methylcellulose (Sigma-Aldrich). After 1 day, the multicellular spheroids were washed three times and placed in fresh media. Two days later, the spheroids were mock infected or exposed to wt T3D or jin-1 at a MOI ¼ 10 pfu 911 per cell. Three days after infection, the spheroids were fixed overnight with 4% formaldehyde and embedded in paraffin. Analyses of 6 mm paraffin sections were performed by 3,3 0 -Diaminobenzidine immunocytochemistry. First, sections were incubated overnight with the primary antibody against Sigma 3 (4F2, DSHB) followed by a wash and subsequent incubation with the secondary horse radish peroxidaseconjugated antibody (Cat. no. P0447, Dako, Glostrup, Denmark).
RESULTS
The aim of our research is to develop an oncolytic virus-based therapy for glioblastoma. To assess the susceptibility, we defined the sensitivity of GSCs to reovirus by measuring five parameters. A panel of seven independent serum-free GSC cultures 23 was evaluated in parallel to the highly reovirus-susceptible human embryonic retinoblast cell line 911 19, 24 and the JAM-A negative U118MG cell line. 19 All of the serum-free GSC cultures are derived from GB resections, five from primary tumor specimens, and two from recurrent disease cases. The characteristics of the patients from whom the GSC cultures were derived are summarized in Table 1 . The expression of the JAM-A reovirus receptor was assessed in each of these cultures by flow cytometry. The expression is heterogeneous and could be categorized in four groups. The GS187 and GS249 cultures were JAM-A negative whereas the GS184 and GS186 have only a low-level of JAM-A expression. Moderate JAM-A expression was measured in GS79 and GS245 cultures, respectively, with between 30 and 50% of the cell population expressing JAM-A. The highest expression was observed in GS224, in which almost the entire population expressed JAM-A ( Figure 1 and Table 2 ). The latter closely resembled the JAM-A expression of the control cell line 911. The high variation in JAM-A expression prompted us to include in our studies the T3D reovirus jin-1. In contrast to the wt T3D, the jin-1 mutants can infect cells independent of JAM-A expression. 19 Within the GSC cultures, a highly variable sensitivity to wt T3D reovirus infection was observed (Table 2 ). In five out of seven GSC cultures, the fraction of reovirus-positive cells did not exceed 1%. This indicates that virus entry in these cultures is inhibited or that the infection is blocked prior to the initiation of reovirus protein synthesis. In contrast, upon wt T3D reovirus exposure, approximately 20% of the GS79 cells were positive for s3, whereas in GS224, more than 50% of the cells synthesized s3 (Table 2) . To establish the EC 50 , each culture was exposed to serial dilutions of the wt T3D reovirus stocks and the viability was determined. No clear cytopathic effects were observed in four GSC cultures. The viability assay demonstrated that GS187 and GS249 are fully resistant to wt T3D. The GS184 and the GS245 cultures exhibited a minimal reduction in viability at the highest MOI used and therefore their EC 50 values were scored as 4100 pfu 911 per cell. Infection of wt T3D was clearly discernible in GS79, GS186 and GS224 cultures (Table 2) . In GS186 cultures, the reovirus cytolysis was not accompanied by reovirus protein synthesis.
To study whether GSC infection results in the production of infectious progeny reovirus, the viral yields were determined at 72 h post infection. From these data, the fold-increase in progeny was calculated (Table 2 ). Significant amounts of progeny virus particles were obtained in six out of the seven GSC cultures. Only from the GS184 culture the amount of reovirus recovered was below the amount used to infect the cultures. The highest yields were collected from GS79 and GS186, with a 20-fold-increase in infectious titer. A 10-fold-increase was produced by GS224. The cultures of GS245 and GS249 both yielded almost four times more virus particles. A doubling of the infectious virus particle number was achieved by GS187. From these data we conclude that several of the GSC cultures are productively infected with wt T3D, albeit with highly variable yields.
In order to determine the virus production per cell, the data of the s3-positive population was combined with the virus yields ( Table 2) . The viral yield per cell obtained from GS79, GS184 and GS224 was low, and does not exceed the 300 pfu 911 per cell. The production per cell from GS187, GS245 and GS249 cultures ranged from 1.5 Â 10 3 to 3 Â 10 3 pfu 911 per cell. The highest yields were produced by GS186 with approximately 10 4 pfu 911 per cell. These data show that, whereas some cultures are susceptible to reovirus infection, they do not replicate reoviruses to high titers.
The GSC cultures were grown as spheroids to study the reovirus spread in 3D cultures that mimic the tumor structure more faithfully than monolayer cultures. 21, 25 Immunocytochemistry revealed the presence of reovirus-infected cells in all GSC spheroid cultures. The distribution and the abundance of the reovirus-infected cells differed within the GSC spheroids (Figure 2 ). In GS184, only a few reovirus-positive cells were detected throughout the spheroid. In GS79 and GS245, the entire outer rim of the spheroids was infected. Already at visual inspection of the spheroid cultures cellular debris was observed surrounding the spheroids. These detached cells were lost during sample processing prior to analysis. In GS187 and GS249, the wt T3D infected cells were concentrated at a single side of the spheroids, suggesting that the virus infection was initiated at a single point near the outer rim, and then spread inward from there. Additionally, visual inspection of GS187 spheroids revealed abnormal blown-up cell structures on the edge of the spheroid, indicative of reovirus infection. The GS224 spheroids showed a mixed pattern of infection with the entire outer layer being reovirus infected in combination with inward spread on one side of the spheroids. On GS186 spheroids, the s3 staining revealed that all cells of the spheroids were infected with the exception of the core cells in a few spheroids. Taken together, these data show that there is a high variation in the extent of reovirus infection and pattern of spreading in the different GSC spheroid cultures.
To study whether the jin-1 mutant is more effective in the GSC cultures, we repeated the experiments described above with this mutant virus. Overall, the fraction of positive cells exceeded the fraction of reovirus positive cells after infection with wt T3D. The cultures with the lowest number of reovirus s3-positive cells included GS184 and GS245. In the GS186, GS187 and GS249 cultures, more than 60% of the cell population stained positive for s3 reovirus protein. Most susceptible to jin-1 were GS79 and GS224 with, respectively, 99 and 89% of the cells being reovirus positive (Table 2) .
Similar to the experiments with wt T3D reovirus, the EC 50 values were determined ( Table 2) . All values of jin-1 infection were found to be lower than after infection with wt T3D. On GS249, a moderate cytopathic effect of jin-1 was seen at MOI ¼ 100. In all the other six cultures, cytopathic effects were clearly seen in higher dilution ranges. The EC 50 determined on GS245 and GS184 was 40 and 26 pfu 911 per cell, respectively. The remaining four cultures scored an EC 50 below 10 pfu 911 per cell. The culture most sensitive to jin-1 was GS186, in which an effect was already observed at MOI ¼ 0.1.
The lowest effective viral progeny yield was obtained from GS79, GS184 and GS224 with less than a hundred-fold-increase in virus titer. Higher yields were obtained in GS245 and GS187 with a 200 and 500-fold amplification, whereas in the GS186 and GS249 cultures the yields exceeded the input dose by three orders of magnitude (Table 2) . Moreover, the calculated yield per infected cell in four of the seven cultures was similar for the jin-1 and wt T3D viruses. In three cultures, the yields per cell were different from those of wt T3D and jin-1. In GS79 and GS186, the yield of progeny virus is higher for wt T3D than for jin-1, whereas in GS184 the yield of the jin-1 was 45-fold higher than in wt T3D-exposed cultures.
To study the distribution and abundance of reovirus-infected cells in 3D cultures, GSC spheroids were exposed to jin-1 (Figure 2 ). Similar to wt T3D, variable results were obtained upon exposure to jin-1. In four GSC spheroids, the cells at the outer rim stained positive for s3, although at varying levels. GS187 and GS249 were more effectively infected than GS79 and GS245. Viral spread into the core of the spheroids was seen in GS184, Reovirus in human glioblastoma stem-like cells SK van den Hengel et al GS186 and GS224. In GS184 and GS224, only some isolated reovirus-infected cells were seen, whereas in GS186 spheroids, s3-stained cells were found throughout the spheroid.
DISCUSSION
The identification of GSCs, their role in tumor recurrence, metastases and therapy resistance, stresses their importance in brain cancer research. Treatment procedures aiming at eliminating these cells may improve brain cancer outcomes. 1, 26 The aim of this study was to test the susceptibility of GSC cultures to the wt mammalian reovirus T3D and the JAM-A-independent jin-1 mutant. In previous studies, the susceptibility to reovirus was tested in tumor cells in serum-supplemented cultures, 27 ,28 which lose their parental tumor characteristics during culturing 7, 8 and therefore may be less representative for the clinical situation.
In this study, we measured the GSC cultures on four parameters -reoviral protein synthesis, the induction of cytopathic effects, the production of progeny virus and the spread and penetration of the virus in a 3D spheroid culture of the GSC. These parameters are all independently evaluated in addition to cell lysis, production and spread. Moreover, because the expression of the high-affinity reovirus receptor JAM-A varied on the GSC cells, we evaluated if jin-1 was more potent in this regard than wt T3D.
From this study we conclude that there is marked heterogeneity between the GSC cultures in their sensitivity to reovirus-mediated cytolysis. The differences in reoviral s3 protein synthesis may reflect variation differences in reovirus binding to the cells, reovirus egress from endosomes or differences in positive-strand messenger RNA generation. 29, 30 The efficiency of reovirus s3 protein synthesis does not correlate with the sensitivity to reovirus-mediated cytolysis. While GS186 is poorly susceptible to wt T3D reovirus synthesis, as evidenced by the fraction of cells that produces s3 proteins, it is relatively sensitive to reovirusinduced cytolysis. In contrast, GS79 synthesizes s3-proteins in a relatively high percentage of the cells, while it is relatively insensitive and requires a high MOI for induction of cytopathic effects by wt T3D. Similarly, we see a highly variable capacity to support reovirus propagation. The amount of progeny reovirus produced per productively infected cells varies over 2 orders of magnitude with the GS186 culture being the most effective wt T3D producer, and the GS224 being least effective. With the use of the jin-1 reovirus, we see a similar heterogeneity. Whereas minor variation is seen in fraction of reovirus-infected cells in the different GSC cultures, the sensitivity to reovirus-induced cytolysis, as well as the capacity to produce progeny reovirus is much more heterogeneous. The infection efficiency, the reovirus-induced cytolysis and the virus production in the monolayer cultures are more efficient with jin-1 than with wt T3D. In contrast, the distribution and abundance of s3-positive cells in spheroid cultures is similar with these viruses. This suggests that the JAM-A receptor expression is not a prime determinant of the reoviruses' capacity to spread in spheroid cultures. Although this was unexpected, it is not unprecedented. Recently it was established that wt T3D infects and spreads efficiently in 3D tumor spheroids established from JAM-A-deficient U118MG cells. In contrast, wt T3D infection of U118MG cells in monolayer cultures is dependent on JAM-A expression (Dautzenberg et al., Factors affecting reovirus spread in 3D cultures; manuscript in preparation). This demonstrates that the canonical T3D entry route, which starts by the reovirus s1 protein's engagement of JAM-A, is not essential in 3D cultures, and that under these growth conditions alternative entry routes can be used by the reovirus.
Spread of the oncolytic viruses within the tumor is essential for anti-tumor efficacy. The compartmentalization brought about by depositions of extracellular matrix presents itself as a physical barrier. 31 Also, the vasculature and the tumor-stroma may impose limitations to viral spread. 32 An appealing option for enhancing the spread of the oncolytic viruses is the use of carrier cells loaded with oncolytic viruses. [33] [34] [35] The carrier cells need to possess the capacity to home to tumors. Several cell types have been identified that can home to tumors, such as dendritic cells, T cells, macrophages and several types of stem cells. After loading, the virus should hitchhike on these cells and be released in the tumor. 34, 35 If the viruses are associating with the cells in a manner that shields them from neutralizing antibodies, the approach may also be effective in those patients with pre-existing neutralizing immunity against reovirus. That this strategy can be applied for reovirus delivery was shown by Ilett et al., 36, 37 who showed that reovirus can hitchhike onto dendritic cells and T cells. Additionally, internalization of reovirus by dendritic cells protected the virus from neutralizing antibodies. 36 So far, only single GSC cultures were established and studied from the individual patients. It therefore remains to be established whether the heterogeneity observed between different cultures faithfully reflects phenotypic inter-patient or inter-tumor variations, or whether the heterogeneity is the result of intratumor heterogeneity 38 or even phenotypic drift in the cultures. The latter could result from the preferential outgrowth of specific populations of cells in the tumor cell cultures. Such culture bias could limit the predictive value as model for the clinical tumors in situ. It would therefore be extremely useful if clinical studies on the efficacy of oncolytic reovirus therapy were paralleled with in vitro studies on reovirus sensitivity in cultures of tumor cells derived from the same patients. Such studies may eventually reveal which of the in vitro parameters would best predict the efficiency of therapeutic reovirus replication in vivo.
